Safety and efficacy of supersaturated oxygen emulsion (ssoe) as a novel topical treatment in open globe injury
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210889
- Recipient
-
The Schepens Eye Research Institute. Inc. UEI XQQJEDK7JC21
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,428,860
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Boston, MA 02114, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $1,428,860 Project Grant to The Schepens Eye Research Institute, Inc. of Boston, MA under the Military Medical Research and Development program (CFDA 12.420) to investigate the safety and efficacy of supersaturated oxygen emulsion (SSOE) as a novel topical treatment for open globe injury. The three-year award beginning September 30, 2022 will support animal research using mice to test SSOE and controls supplied by sub-awardee Coruna Medical LLC. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions for battlefield injuries and beyond. This award advances those goals by exploring SSOE's potential to treat serious eye wounds.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Coruna Medical Inc. | $75,000 |
Quick answers
Who received award W81XWH2210889?
W81XWH2210889 was awarded to The Schepens Eye Research Institute. Inc. by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2210889 worth?
$1,428,860 has been obligated on W81XWH2210889.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award